https://bitox.bsmo.be/esmo-congress-2025/2026-03-23T15:24:21+01:00https://bitox.bsmo.be/bsmo-bordet-meeting-2026/2026-06-30T09:31:33+02:00https://bitox.bsmo.be/post-esmo-2025-fr/2026-03-23T15:29:54+01:00https://bitox.bsmo.be/post-esmo-2025-nl/2026-03-23T15:28:08+01:00https://bitox.bsmo.be/arthralgia/2025-01-18T22:46:41+01:00https://bitox.bsmo.be/joint-pathology/2025-01-18T22:20:11+01:00https://bitox.bsmo.be/task-force-breast-cancer/2026-01-17T14:56:20+01:00https://bitox.bsmo.be/task-force-cancer-survivorship-8286/2026-03-25T17:09:09+01:00https://bitox.bsmo.be/task-force-geriatric-oncology-8288/2026-01-26T13:20:57+01:00https://bitox.bsmo.be/task-force-immuno-tf-bitox-8291/2026-01-23T12:07:46+01:00https://bitox.bsmo.be/task-force-supportive-care-8293/2026-01-17T14:55:40+01:00https://bitox.bsmo.be/task-force-bmuc-8296/2026-01-17T14:21:14+01:00https://bitox.bsmo.be/task-force-yoc-8300/2026-01-17T15:00:02+01:00https://bitox.bsmo.be/task-force-bado/2026-01-17T14:18:52+01:00https://bitox.bsmo.be/task-force-head-neck-cancer/2026-01-17T14:42:50+01:00https://bitox.bsmo.be/task-force-gynaecological-cancer/2026-01-17T14:28:36+01:00https://bitox.bsmo.be/task-force-e-oncology/2026-01-17T14:45:46+01:00https://bitox.bsmo.be/task-force-sustainability/2026-02-11T13:39:29+01:00https://bitox.bsmo.be/mbc-symposium-2025/2026-04-15T09:42:19+02:00https://bitox.bsmo.be/bitox-immunomanager/2025-07-15T10:57:08+02:00https://bitox.bsmo.be/0-immune-related-adverse-events-irae/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-thank-you/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-skin-toxicity/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-neurological-side-effects/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-peripheral-neurological-toxicity/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-central-neurological-toxicity/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-endocrine/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-mild-uncomplicated-peripheral-neuropathy/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-moderate-uncomplicated-peripheral-neuropathy/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-uncomplicated-peripheral-neuropathy/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-aseptic-meningitis/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-mild-aseptic-meningitis/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-severe-aseptic-meningitis/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-encephalitis/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-transversal-myelitis/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-0-guillain-barre-syndrome/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-joint-pathology/2025-04-26T13:58:56+02:00https://bitox.bsmo.be/0-arthralgia/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-artritis/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-0-did-the-diarrhea-stop-within-72h-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-0-did-the-diarrhea-stop-within-72h-1/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-0-did-the-diarrhea-stop-within-72h-and-no-recurrence-on-day-4-and-5/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-0-colitis/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-skin-toxicity-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-skin-toxicity-2-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-0-hepatitis/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-nephritis/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-pneumonitis/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hypothyroidism/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hyperthyroidism/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hypophysitis/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-muscle-pathology/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-polymyalgia-rheumatica/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-myositis/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-myastenia-gravis/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-0-colitis-medium-risk/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hypophysitis-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-skin-toxicity-3/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-skin-toxicity-grade-2-4-sequel/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-belgian-multidisciplinary-immunotoxicity-board-bitox/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-joint-pathology-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-arthralgia-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-arthralgia-grade-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-arthralgia-grade-1/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-arthritis/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-colitis/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-colitis-grade-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-colitis-grade-3-or-4/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-colitis-grade-2-low-risk/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-colitis-grade-2-medium-risk/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-colitis-low-risk-yes/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-colitis-low-risk-no/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-colitis-medium-risk-yes/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-colitis-medium-risk-no/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-colitis-medium-risk-no-yes/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-colitis-medium-risk-no-no/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-colitis-medium-risk-no-no-yes/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-colitis-medium-risk-no-no-no/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-skin-toxicity-4/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-skin-toxicity-grade-1/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-skin-toxicity-grade-2-4/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-skin-toxicity-grade-2-4-low-risk/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-skin-toxicity-grade-2-4-medium-risk/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-skin-toxicity-grade-2-4-high-risk/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hepatitis/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hepatitis-grade-1/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hepatitis-grade-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hepatitis-grade-3/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hepatitis-grade-4/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-nephritis-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-nephritis-grade-1/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-nephritis-grade-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-nephritis-grade-3/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-nephritis-grade-4/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-neurologic/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-peripheral-neurological-toxicity-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-uncomplicated-peripheral-neuropathy-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-uncomplicated-peripheral-neuropathy-mild/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-uncomplicated-peripheral-neuropathy-moderate/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-uncomplicated-peripheral-neuropathy-severe/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-peripheral-neuropathy-guillain-barre-syndrome/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-central-neurological-toxicity-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-transversal-myelitis-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-encephalitis-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-aseptic-meningitis-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-aseptic-meningitis-mild/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-aseptic-meningitis-severe/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-pneumonitis-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-pneumonitis-grade-1/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-pneumonitis-grade-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-pneumonitis-grade-3-or-4/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hypothyroidism-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hypothyroidism-clinical/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hypothyroidism-severe/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hypothyroidism-grade-4/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hyperthyroidism-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hyperthyroidism-grade-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hyperthyroidism-grade-1/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hyperthyroidism-grade-3/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hyperthyroidism-grade-4/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hypophysitis-3/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-silent-hypophysitis/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hypophysitis-with-headache/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-muscle-pathology-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-polymyalgia-rheumatica-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-myositis-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-myositis-grade-1/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-myositis-grade-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-myastenia-gravis-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hypothyroidism-subclinical/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hyperthyroidism-asymptomatic/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hyperthyroidism-symptomatic/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hyperthyroidism-severe/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-diabetes-mellitus/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-diabetes-mellitus-severe/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-diabetes-mellitus-normal/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-adrenalitis/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-adrenalitis-asymptomatic-or-mild/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-adrenalitis-severe/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hypophysitis-4/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-silent-hypophysitis-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hypophysitis-5/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-combination-therapy-ici-tki/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-hyperthyroidism-3/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-ae-possibly-related-to-both-ici-and-tki/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-ae-considered-related-to-tki/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/0-ae-considered-related-to-tki-2/2024-04-04T00:00:00+02:00https://bitox.bsmo.be/arthralgia-2/2025-04-19T21:49:41+02:00https://bitox.bsmo.be/arthralgia-grade-1/2025-04-26T15:23:47+02:00https://bitox.bsmo.be/series-on-molecular-medicine/2026-05-21T16:52:52+02:00https://bitox.bsmo.be/task-force-quality-assurance/2026-01-17T14:14:17+01:00https://bitox.bsmo.be/29th-annual-bsmo-meeting-2027/2026-06-16T15:21:45+02:00https://bitox.bsmo.be/bsmo-webinar-beyond-treatment-the-power-of-nutrition-in-oncology/2026-06-12T12:22:00+02:00